AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional ...

This Somerville biotech company is gearing up to lay off more than 80 employees in Massachusetts this year. Here's what we ...

Pande has a new venture capital firm in the works, dubbed VZVC. He co-founded the firm with startup investor Zack Werner last ...

Lyra Therapeutics is abandoning work on its rhinosinusitis treatment and laying off its remaining employees.

He Jiankui spent three years in prison after creating gene-edited babies. Now back at work, he sees a greater opening for ...

The early-stage results have been described as outstanding. The post Early success in battling Crohn's Disease has sent this ...

Mature biopharma deals are stealing all the headlines, but Bristol Myers Squibb’s Robert Plenge says the company’s deals with ...

The addressable market for this newly approved software is huge. The post This ASX biotech's shares are up strongly on good ...

The life sciences world is once again converging in San Francisco as the J.P. Morgan Healthcare Conference kicks off for 2026 ...

Insmed's CEO said months ago that the commercial opportunity for the biotech's newly approved lung disease drug was "huge." ...

Several Bay Area biotech companies announced big funding rounds totaling hundreds of millions of dollars just before the ...

Learn how spectroscopy facilitates non-invasive, real-time bio-monitoring, enhancing decision-making in healthcare, ...